nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0785	0.135	CbGbCtD
Triazolam—CYP3A7—Irinotecan—stomach cancer	0.0785	0.135	CbGbCtD
Triazolam—CYP2C9—Capecitabine—stomach cancer	0.0639	0.11	CbGbCtD
Triazolam—CYP3A5—Irinotecan—stomach cancer	0.0589	0.101	CbGbCtD
Triazolam—CYP3A7—Docetaxel—stomach cancer	0.0575	0.0988	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0575	0.0988	CbGbCtD
Triazolam—CYP2C8—Fluorouracil—stomach cancer	0.0543	0.0933	CbGbCtD
Triazolam—CYP3A5—Docetaxel—stomach cancer	0.0432	0.0741	CbGbCtD
Triazolam—CYP2C9—Fluorouracil—stomach cancer	0.0379	0.0651	CbGbCtD
Triazolam—CYP3A4—Irinotecan—stomach cancer	0.023	0.0394	CbGbCtD
Triazolam—CYP3A4—Docetaxel—stomach cancer	0.0168	0.0289	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—stomach cancer	0.0125	0.0215	CbGbCtD
Triazolam—Anorexia—Fluorouracil—stomach cancer	0.000774	0.00205	CcSEcCtD
Triazolam—Visual impairment—Capecitabine—stomach cancer	0.00077	0.00204	CcSEcCtD
Triazolam—Insomnia—Irinotecan—stomach cancer	0.000767	0.00203	CcSEcCtD
Triazolam—Mood swings—Epirubicin—stomach cancer	0.000762	0.00202	CcSEcCtD
Triazolam—Paraesthesia—Irinotecan—stomach cancer	0.000761	0.00202	CcSEcCtD
Triazolam—Ataxia—Epirubicin—stomach cancer	0.000756	0.00201	CcSEcCtD
Triazolam—Dyspnoea—Irinotecan—stomach cancer	0.000756	0.00201	CcSEcCtD
Triazolam—Somnolence—Irinotecan—stomach cancer	0.000754	0.002	CcSEcCtD
Triazolam—Tinnitus—Capecitabine—stomach cancer	0.000745	0.00198	CcSEcCtD
Triazolam—Osteoarthritis—Doxorubicin—stomach cancer	0.000744	0.00197	CcSEcCtD
Triazolam—Decreased appetite—Irinotecan—stomach cancer	0.000737	0.00196	CcSEcCtD
Triazolam—Insomnia—Fluorouracil—stomach cancer	0.000734	0.00195	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—stomach cancer	0.000733	0.00194	CcSEcCtD
Triazolam—Fatigue—Irinotecan—stomach cancer	0.000731	0.00194	CcSEcCtD
Triazolam—Paraesthesia—Fluorouracil—stomach cancer	0.000729	0.00193	CcSEcCtD
Triazolam—Pain—Irinotecan—stomach cancer	0.000725	0.00192	CcSEcCtD
Triazolam—Constipation—Irinotecan—stomach cancer	0.000725	0.00192	CcSEcCtD
Triazolam—Dyspnoea—Fluorouracil—stomach cancer	0.000724	0.00192	CcSEcCtD
Triazolam—Somnolence—Fluorouracil—stomach cancer	0.000722	0.00192	CcSEcCtD
Triazolam—Erythema—Docetaxel—stomach cancer	0.000718	0.00191	CcSEcCtD
Triazolam—Muscular weakness—Epirubicin—stomach cancer	0.000709	0.00188	CcSEcCtD
Triazolam—Decreased appetite—Fluorouracil—stomach cancer	0.000706	0.00187	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—stomach cancer	0.000705	0.00187	CcSEcCtD
Triazolam—Dysgeusia—Docetaxel—stomach cancer	0.000703	0.00187	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—stomach cancer	0.0007	0.00186	CcSEcCtD
Triazolam—Feeling abnormal—Irinotecan—stomach cancer	0.000699	0.00185	CcSEcCtD
Triazolam—Erythema—Capecitabine—stomach cancer	0.000695	0.00184	CcSEcCtD
Triazolam—Dysuria—Methotrexate—stomach cancer	0.000695	0.00184	CcSEcCtD
Triazolam—Pain—Fluorouracil—stomach cancer	0.000694	0.00184	CcSEcCtD
Triazolam—Gastrointestinal pain—Irinotecan—stomach cancer	0.000693	0.00184	CcSEcCtD
Triazolam—Muscle spasms—Docetaxel—stomach cancer	0.00069	0.00183	CcSEcCtD
Triazolam—Flatulence—Capecitabine—stomach cancer	0.000685	0.00182	CcSEcCtD
Triazolam—Dysgeusia—Capecitabine—stomach cancer	0.000681	0.00181	CcSEcCtD
Triazolam—Abdominal pain—Irinotecan—stomach cancer	0.00067	0.00178	CcSEcCtD
Triazolam—Feeling abnormal—Fluorouracil—stomach cancer	0.000669	0.00178	CcSEcCtD
Triazolam—Muscle spasms—Capecitabine—stomach cancer	0.000668	0.00177	CcSEcCtD
Triazolam—Drowsiness—Methotrexate—stomach cancer	0.000662	0.00176	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—stomach cancer	0.000656	0.00174	CcSEcCtD
Triazolam—Tremor—Capecitabine—stomach cancer	0.000651	0.00173	CcSEcCtD
Triazolam—Dysuria—Epirubicin—stomach cancer	0.00065	0.00172	CcSEcCtD
Triazolam—Stomatitis—Methotrexate—stomach cancer	0.000646	0.00171	CcSEcCtD
Triazolam—Ill-defined disorder—Capecitabine—stomach cancer	0.000645	0.00171	CcSEcCtD
Triazolam—Syncope—Docetaxel—stomach cancer	0.000644	0.00171	CcSEcCtD
Triazolam—Palpitations—Docetaxel—stomach cancer	0.000635	0.00168	CcSEcCtD
Triazolam—Loss of consciousness—Docetaxel—stomach cancer	0.000631	0.00167	CcSEcCtD
Triazolam—Malaise—Capecitabine—stomach cancer	0.000627	0.00166	CcSEcCtD
Triazolam—Hypersensitivity—Irinotecan—stomach cancer	0.000625	0.00166	CcSEcCtD
Triazolam—Syncope—Capecitabine—stomach cancer	0.000624	0.00165	CcSEcCtD
Triazolam—Hypertension—Docetaxel—stomach cancer	0.00062	0.00165	CcSEcCtD
Triazolam—Drowsiness—Epirubicin—stomach cancer	0.00062	0.00164	CcSEcCtD
Triazolam—Palpitations—Capecitabine—stomach cancer	0.000614	0.00163	CcSEcCtD
Triazolam—Chest pain—Docetaxel—stomach cancer	0.000611	0.00162	CcSEcCtD
Triazolam—Loss of consciousness—Capecitabine—stomach cancer	0.000611	0.00162	CcSEcCtD
Triazolam—Asthenia—Irinotecan—stomach cancer	0.000608	0.00161	CcSEcCtD
Triazolam—Jaundice—Epirubicin—stomach cancer	0.000604	0.0016	CcSEcCtD
Triazolam—Stomatitis—Epirubicin—stomach cancer	0.000604	0.0016	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—stomach cancer	0.000601	0.0016	CcSEcCtD
Triazolam—Hypertension—Capecitabine—stomach cancer	0.0006	0.00159	CcSEcCtD
Triazolam—Hypersensitivity—Fluorouracil—stomach cancer	0.000598	0.00159	CcSEcCtD
Triazolam—Dry mouth—Docetaxel—stomach cancer	0.000598	0.00159	CcSEcCtD
Triazolam—Chest pain—Capecitabine—stomach cancer	0.000592	0.00157	CcSEcCtD
Triazolam—Confusional state—Docetaxel—stomach cancer	0.000591	0.00157	CcSEcCtD
Triazolam—Anxiety—Capecitabine—stomach cancer	0.00059	0.00157	CcSEcCtD
Triazolam—Oedema—Docetaxel—stomach cancer	0.000586	0.00156	CcSEcCtD
Triazolam—Discomfort—Capecitabine—stomach cancer	0.000585	0.00155	CcSEcCtD
Triazolam—Diarrhoea—Irinotecan—stomach cancer	0.00058	0.00154	CcSEcCtD
Triazolam—Dry mouth—Capecitabine—stomach cancer	0.000579	0.00154	CcSEcCtD
Triazolam—Shock—Docetaxel—stomach cancer	0.000577	0.00153	CcSEcCtD
Triazolam—Pruritus—Fluorouracil—stomach cancer	0.000575	0.00152	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—stomach cancer	0.000574	0.00152	CcSEcCtD
Triazolam—Visual impairment—Methotrexate—stomach cancer	0.000573	0.00152	CcSEcCtD
Triazolam—Confusional state—Capecitabine—stomach cancer	0.000572	0.00152	CcSEcCtD
Triazolam—Tachycardia—Docetaxel—stomach cancer	0.000572	0.00152	CcSEcCtD
Triazolam—Oedema—Capecitabine—stomach cancer	0.000567	0.00151	CcSEcCtD
Triazolam—Dizziness—Irinotecan—stomach cancer	0.000561	0.00149	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—stomach cancer	0.000559	0.00148	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—stomach cancer	0.000559	0.00148	CcSEcCtD
Triazolam—Anorexia—Docetaxel—stomach cancer	0.000559	0.00148	CcSEcCtD
Triazolam—Shock—Capecitabine—stomach cancer	0.000558	0.00148	CcSEcCtD
Triazolam—Diarrhoea—Fluorouracil—stomach cancer	0.000556	0.00147	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—stomach cancer	0.000554	0.00147	CcSEcCtD
Triazolam—Tachycardia—Capecitabine—stomach cancer	0.000554	0.00147	CcSEcCtD
Triazolam—Hyperhidrosis—Capecitabine—stomach cancer	0.000549	0.00146	CcSEcCtD
Triazolam—Anorexia—Capecitabine—stomach cancer	0.000541	0.00144	CcSEcCtD
Triazolam—Vomiting—Irinotecan—stomach cancer	0.000539	0.00143	CcSEcCtD
Triazolam—Dizziness—Fluorouracil—stomach cancer	0.000537	0.00142	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—stomach cancer	0.000536	0.00142	CcSEcCtD
Triazolam—Dermatitis—Irinotecan—stomach cancer	0.000534	0.00142	CcSEcCtD
Triazolam—Headache—Irinotecan—stomach cancer	0.000531	0.00141	CcSEcCtD
Triazolam—Insomnia—Docetaxel—stomach cancer	0.00053	0.00141	CcSEcCtD
Triazolam—Paraesthesia—Docetaxel—stomach cancer	0.000526	0.0014	CcSEcCtD
Triazolam—Dyspnoea—Docetaxel—stomach cancer	0.000523	0.00139	CcSEcCtD
Triazolam—Somnolence—Docetaxel—stomach cancer	0.000521	0.00138	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—stomach cancer	0.000519	0.00138	CcSEcCtD
Triazolam—Erythema—Methotrexate—stomach cancer	0.000518	0.00137	CcSEcCtD
Triazolam—Vomiting—Fluorouracil—stomach cancer	0.000516	0.00137	CcSEcCtD
Triazolam—Insomnia—Capecitabine—stomach cancer	0.000513	0.00136	CcSEcCtD
Triazolam—Dermatitis—Fluorouracil—stomach cancer	0.000512	0.00136	CcSEcCtD
Triazolam—Paraesthesia—Capecitabine—stomach cancer	0.00051	0.00135	CcSEcCtD
Triazolam—Decreased appetite—Docetaxel—stomach cancer	0.000509	0.00135	CcSEcCtD
Triazolam—Headache—Fluorouracil—stomach cancer	0.000509	0.00135	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—stomach cancer	0.000507	0.00134	CcSEcCtD
Triazolam—Dyspnoea—Capecitabine—stomach cancer	0.000506	0.00134	CcSEcCtD
Triazolam—Fatigue—Docetaxel—stomach cancer	0.000505	0.00134	CcSEcCtD
Triazolam—Nausea—Irinotecan—stomach cancer	0.000504	0.00134	CcSEcCtD
Triazolam—Pain—Docetaxel—stomach cancer	0.000501	0.00133	CcSEcCtD
Triazolam—Constipation—Docetaxel—stomach cancer	0.000501	0.00133	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—stomach cancer	0.000496	0.00132	CcSEcCtD
Triazolam—Decreased appetite—Capecitabine—stomach cancer	0.000493	0.00131	CcSEcCtD
Triazolam—Fatigue—Capecitabine—stomach cancer	0.000489	0.0013	CcSEcCtD
Triazolam—Constipation—Capecitabine—stomach cancer	0.000485	0.00129	CcSEcCtD
Triazolam—Pain—Capecitabine—stomach cancer	0.000485	0.00129	CcSEcCtD
Triazolam—Erythema—Epirubicin—stomach cancer	0.000484	0.00129	CcSEcCtD
Triazolam—Feeling abnormal—Docetaxel—stomach cancer	0.000483	0.00128	CcSEcCtD
Triazolam—Nausea—Fluorouracil—stomach cancer	0.000482	0.00128	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—stomach cancer	0.00048	0.00127	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—stomach cancer	0.00048	0.00127	CcSEcCtD
Triazolam—Gastrointestinal pain—Docetaxel—stomach cancer	0.000479	0.00127	CcSEcCtD
Triazolam—Flatulence—Epirubicin—stomach cancer	0.000477	0.00127	CcSEcCtD
Triazolam—Tension—Epirubicin—stomach cancer	0.000475	0.00126	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—stomach cancer	0.000474	0.00126	CcSEcCtD
Triazolam—Nervousness—Epirubicin—stomach cancer	0.00047	0.00125	CcSEcCtD
Triazolam—Feeling abnormal—Capecitabine—stomach cancer	0.000468	0.00124	CcSEcCtD
Triazolam—Malaise—Methotrexate—stomach cancer	0.000467	0.00124	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—stomach cancer	0.000466	0.00124	CcSEcCtD
Triazolam—Gastrointestinal pain—Capecitabine—stomach cancer	0.000464	0.00123	CcSEcCtD
Triazolam—Abdominal pain—Docetaxel—stomach cancer	0.000463	0.00123	CcSEcCtD
Triazolam—Ill-defined disorder—Epirubicin—stomach cancer	0.000449	0.00119	CcSEcCtD
Triazolam—Abdominal pain—Capecitabine—stomach cancer	0.000449	0.00119	CcSEcCtD
Triazolam—Erythema—Doxorubicin—stomach cancer	0.000448	0.00119	CcSEcCtD
Triazolam—Agitation—Epirubicin—stomach cancer	0.000445	0.00118	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—stomach cancer	0.000442	0.00117	CcSEcCtD
Triazolam—Chest pain—Methotrexate—stomach cancer	0.000441	0.00117	CcSEcCtD
Triazolam—Tension—Doxorubicin—stomach cancer	0.00044	0.00117	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—stomach cancer	0.000439	0.00116	CcSEcCtD
Triazolam—Malaise—Epirubicin—stomach cancer	0.000437	0.00116	CcSEcCtD
Triazolam—Discomfort—Methotrexate—stomach cancer	0.000435	0.00116	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—stomach cancer	0.000435	0.00116	CcSEcCtD
Triazolam—Syncope—Epirubicin—stomach cancer	0.000434	0.00115	CcSEcCtD
Triazolam—Hypersensitivity—Docetaxel—stomach cancer	0.000432	0.00115	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—stomach cancer	0.000431	0.00114	CcSEcCtD
Triazolam—Palpitations—Epirubicin—stomach cancer	0.000428	0.00114	CcSEcCtD
Triazolam—Confusional state—Methotrexate—stomach cancer	0.000426	0.00113	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—stomach cancer	0.000426	0.00113	CcSEcCtD
Triazolam—Asthenia—Docetaxel—stomach cancer	0.000421	0.00112	CcSEcCtD
Triazolam—Hypertension—Epirubicin—stomach cancer	0.000418	0.00111	CcSEcCtD
Triazolam—Hypersensitivity—Capecitabine—stomach cancer	0.000418	0.00111	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—stomach cancer	0.000416	0.0011	CcSEcCtD
Triazolam—Pruritus—Docetaxel—stomach cancer	0.000415	0.0011	CcSEcCtD
Triazolam—Chest pain—Epirubicin—stomach cancer	0.000412	0.00109	CcSEcCtD
Triazolam—Agitation—Doxorubicin—stomach cancer	0.000412	0.00109	CcSEcCtD
Triazolam—Anxiety—Epirubicin—stomach cancer	0.000411	0.00109	CcSEcCtD
Triazolam—Hyperhidrosis—Methotrexate—stomach cancer	0.000408	0.00108	CcSEcCtD
Triazolam—Discomfort—Epirubicin—stomach cancer	0.000407	0.00108	CcSEcCtD
Triazolam—Asthenia—Capecitabine—stomach cancer	0.000407	0.00108	CcSEcCtD
Triazolam—Malaise—Doxorubicin—stomach cancer	0.000404	0.00107	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—stomach cancer	0.000403	0.00107	CcSEcCtD
Triazolam—Anorexia—Methotrexate—stomach cancer	0.000403	0.00107	CcSEcCtD
Triazolam—Syncope—Doxorubicin—stomach cancer	0.000402	0.00107	CcSEcCtD
Triazolam—Pruritus—Capecitabine—stomach cancer	0.000401	0.00107	CcSEcCtD
Triazolam—Diarrhoea—Docetaxel—stomach cancer	0.000401	0.00106	CcSEcCtD
Triazolam—Confusional state—Epirubicin—stomach cancer	0.000399	0.00106	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—stomach cancer	0.000396	0.00105	CcSEcCtD
Triazolam—Oedema—Epirubicin—stomach cancer	0.000395	0.00105	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—stomach cancer	0.000394	0.00105	CcSEcCtD
Triazolam—Shock—Epirubicin—stomach cancer	0.000389	0.00103	CcSEcCtD
Triazolam—Diarrhoea—Capecitabine—stomach cancer	0.000388	0.00103	CcSEcCtD
Triazolam—Dizziness—Docetaxel—stomach cancer	0.000388	0.00103	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—stomach cancer	0.000387	0.00103	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—stomach cancer	0.000386	0.00102	CcSEcCtD
Triazolam—Hyperhidrosis—Epirubicin—stomach cancer	0.000382	0.00101	CcSEcCtD
Triazolam—Insomnia—Methotrexate—stomach cancer	0.000382	0.00101	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—stomach cancer	0.000382	0.00101	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—stomach cancer	0.00038	0.00101	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—stomach cancer	0.000379	0.00101	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—stomach cancer	0.000377	0.001	CcSEcCtD
Triazolam—Anorexia—Epirubicin—stomach cancer	0.000377	0.001	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—stomach cancer	0.000377	0.000999	CcSEcCtD
Triazolam—Somnolence—Methotrexate—stomach cancer	0.000376	0.000996	CcSEcCtD
Triazolam—Dizziness—Capecitabine—stomach cancer	0.000375	0.000996	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—stomach cancer	0.000373	0.00099	CcSEcCtD
Triazolam—Vomiting—Docetaxel—stomach cancer	0.000373	0.000989	CcSEcCtD
Triazolam—Dermatitis—Docetaxel—stomach cancer	0.000369	0.00098	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—stomach cancer	0.000369	0.000979	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—stomach cancer	0.000367	0.000974	CcSEcCtD
Triazolam—Headache—Docetaxel—stomach cancer	0.000367	0.000974	CcSEcCtD
Triazolam—Oedema—Doxorubicin—stomach cancer	0.000366	0.000971	CcSEcCtD
Triazolam—Fatigue—Methotrexate—stomach cancer	0.000364	0.000966	CcSEcCtD
Triazolam—Pain—Methotrexate—stomach cancer	0.000361	0.000958	CcSEcCtD
Triazolam—Vomiting—Capecitabine—stomach cancer	0.000361	0.000957	CcSEcCtD
Triazolam—Shock—Doxorubicin—stomach cancer	0.00036	0.000955	CcSEcCtD
Triazolam—Insomnia—Epirubicin—stomach cancer	0.000358	0.000949	CcSEcCtD
Triazolam—Dermatitis—Capecitabine—stomach cancer	0.000357	0.000948	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—stomach cancer	0.000357	0.000947	CcSEcCtD
Triazolam—Headache—Capecitabine—stomach cancer	0.000355	0.000943	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—stomach cancer	0.000355	0.000942	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—stomach cancer	0.000354	0.000938	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—stomach cancer	0.000352	0.000935	CcSEcCtD
Triazolam—Somnolence—Epirubicin—stomach cancer	0.000351	0.000933	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—stomach cancer	0.000349	0.000925	CcSEcCtD
Triazolam—Nausea—Docetaxel—stomach cancer	0.000348	0.000924	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—stomach cancer	0.000348	0.000924	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—stomach cancer	0.000345	0.000917	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—stomach cancer	0.000344	0.000912	CcSEcCtD
Triazolam—Fatigue—Epirubicin—stomach cancer	0.000341	0.000904	CcSEcCtD
Triazolam—Constipation—Epirubicin—stomach cancer	0.000338	0.000897	CcSEcCtD
Triazolam—Pain—Epirubicin—stomach cancer	0.000338	0.000897	CcSEcCtD
Triazolam—Nausea—Capecitabine—stomach cancer	0.000337	0.000894	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—stomach cancer	0.000334	0.000886	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—stomach cancer	0.000331	0.000878	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—stomach cancer	0.000328	0.000872	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—stomach cancer	0.000326	0.000865	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—stomach cancer	0.000326	0.000864	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—stomach cancer	0.000325	0.000863	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—stomach cancer	0.000323	0.000858	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—stomach cancer	0.000318	0.000844	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—stomach cancer	0.000315	0.000837	CcSEcCtD
Triazolam—Pain—Doxorubicin—stomach cancer	0.000313	0.00083	CcSEcCtD
Triazolam—Constipation—Doxorubicin—stomach cancer	0.000313	0.00083	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—stomach cancer	0.000313	0.000829	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—stomach cancer	0.000311	0.000826	CcSEcCtD
Triazolam—Asthenia—Methotrexate—stomach cancer	0.000303	0.000804	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—stomach cancer	0.000301	0.0008	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000299	0.000794	CcSEcCtD
Triazolam—Pruritus—Methotrexate—stomach cancer	0.000299	0.000793	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—stomach cancer	0.000291	0.000773	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—stomach cancer	0.000289	0.000767	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—stomach cancer	0.000289	0.000767	CcSEcCtD
Triazolam—Asthenia—Epirubicin—stomach cancer	0.000284	0.000753	CcSEcCtD
Triazolam—Pruritus—Epirubicin—stomach cancer	0.00028	0.000742	CcSEcCtD
Triazolam—Dizziness—Methotrexate—stomach cancer	0.000279	0.000741	CcSEcCtD
Triazolam—Diarrhoea—Epirubicin—stomach cancer	0.00027	0.000718	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—stomach cancer	0.000269	0.000715	CcSEcCtD
Triazolam—Vomiting—Methotrexate—stomach cancer	0.000269	0.000713	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—stomach cancer	0.000266	0.000706	CcSEcCtD
Triazolam—Headache—Methotrexate—stomach cancer	0.000265	0.000702	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—stomach cancer	0.000262	0.000696	CcSEcCtD
Triazolam—Dizziness—Epirubicin—stomach cancer	0.000261	0.000694	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—stomach cancer	0.000259	0.000687	CcSEcCtD
Triazolam—Vomiting—Epirubicin—stomach cancer	0.000251	0.000667	CcSEcCtD
Triazolam—Nausea—Methotrexate—stomach cancer	0.000251	0.000666	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—stomach cancer	0.00025	0.000664	CcSEcCtD
Triazolam—Dermatitis—Epirubicin—stomach cancer	0.000249	0.000661	CcSEcCtD
Triazolam—Headache—Epirubicin—stomach cancer	0.000248	0.000657	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—stomach cancer	0.000242	0.000642	CcSEcCtD
Triazolam—Nausea—Epirubicin—stomach cancer	0.000235	0.000623	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—stomach cancer	0.000233	0.000617	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—stomach cancer	0.00023	0.000611	CcSEcCtD
Triazolam—Headache—Doxorubicin—stomach cancer	0.000229	0.000608	CcSEcCtD
Triazolam—Nausea—Doxorubicin—stomach cancer	0.000217	0.000576	CcSEcCtD
Triazolam—GABRG3—Transmembrane transport of small molecules—ALB—stomach cancer	2.01e-05	0.000496	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—APOA1—stomach cancer	2e-05	0.000494	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPAP2A—stomach cancer	1.99e-05	0.000493	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—APOA1—stomach cancer	1.99e-05	0.000491	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—HRAS—stomach cancer	1.99e-05	0.000491	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.98e-05	0.000489	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—APOA1—stomach cancer	1.95e-05	0.000482	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—MAPK1—stomach cancer	1.95e-05	0.000482	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—HRAS—stomach cancer	1.95e-05	0.000482	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTP1—stomach cancer	1.93e-05	0.000477	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLIN2—stomach cancer	1.93e-05	0.000477	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.92e-05	0.000474	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—HRAS—stomach cancer	1.92e-05	0.000473	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NDUFV1—stomach cancer	1.91e-05	0.000472	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NDUFS1—stomach cancer	1.91e-05	0.000472	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL6—stomach cancer	1.91e-05	0.000471	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	1.91e-05	0.000471	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—HRAS—stomach cancer	1.9e-05	0.00047	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—MAPK1—stomach cancer	1.89e-05	0.000468	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SREBF2—stomach cancer	1.89e-05	0.000468	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CA2—stomach cancer	1.88e-05	0.000464	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—ALB—stomach cancer	1.87e-05	0.000463	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—RORA—stomach cancer	1.87e-05	0.000462	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—HRAS—stomach cancer	1.87e-05	0.000462	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	1.87e-05	0.000461	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—MAPK1—stomach cancer	1.86e-05	0.00046	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—HRAS—stomach cancer	1.86e-05	0.00046	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—ALB—stomach cancer	1.85e-05	0.000457	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—HRAS—stomach cancer	1.83e-05	0.000453	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PGAM1—stomach cancer	1.83e-05	0.000452	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NT5E—stomach cancer	1.83e-05	0.000452	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—MAPK1—stomach cancer	1.83e-05	0.000452	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—MAPK1—stomach cancer	1.82e-05	0.000449	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—MAPK1—stomach cancer	1.78e-05	0.000441	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CKB—stomach cancer	1.78e-05	0.000439	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CA1—stomach cancer	1.78e-05	0.000439	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—FBP1—stomach cancer	1.78e-05	0.000439	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NDUFA2—stomach cancer	1.78e-05	0.000439	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTM1—stomach cancer	1.78e-05	0.000439	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALDOB—stomach cancer	1.75e-05	0.000433	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	1.75e-05	0.000433	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLCE1—stomach cancer	1.74e-05	0.000431	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALDH7A1—stomach cancer	1.74e-05	0.000431	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—HRAS—stomach cancer	1.73e-05	0.000428	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—HRAS—stomach cancer	1.71e-05	0.000423	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.71e-05	0.000422	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PGLS—stomach cancer	1.7e-05	0.00042	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BLVRB—stomach cancer	1.7e-05	0.00042	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ALB—stomach cancer	1.69e-05	0.000418	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—UMPS—stomach cancer	1.67e-05	0.000413	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLIN2—stomach cancer	1.67e-05	0.000413	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ACAD8—stomach cancer	1.66e-05	0.00041	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ALB—stomach cancer	1.64e-05	0.000406	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—HRAS—stomach cancer	1.63e-05	0.000404	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALOX5—stomach cancer	1.63e-05	0.000403	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CA2—stomach cancer	1.63e-05	0.000402	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPAP2A—stomach cancer	1.62e-05	0.000401	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ALB—stomach cancer	1.61e-05	0.000399	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—DPYD—stomach cancer	1.6e-05	0.000396	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ALB—stomach cancer	1.58e-05	0.000392	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PGAM1—stomach cancer	1.58e-05	0.000391	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NT5E—stomach cancer	1.58e-05	0.000391	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ALB—stomach cancer	1.57e-05	0.000389	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—HRAS—stomach cancer	1.57e-05	0.000387	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.56e-05	0.000386	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—MAPK1—stomach cancer	1.56e-05	0.000385	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PDHA1—stomach cancer	1.55e-05	0.000384	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ECHS1—stomach cancer	1.55e-05	0.000384	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ALB—stomach cancer	1.55e-05	0.000382	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—HRAS—stomach cancer	1.52e-05	0.000376	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLCE1—stomach cancer	1.51e-05	0.000373	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDH7A1—stomach cancer	1.51e-05	0.000373	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—HRAS—stomach cancer	1.49e-05	0.000369	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GMPR2—stomach cancer	1.48e-05	0.000366	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—HRAS—stomach cancer	1.47e-05	0.000363	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TYMP—stomach cancer	1.46e-05	0.000361	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—FADS1—stomach cancer	1.46e-05	0.000361	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—HRAS—stomach cancer	1.46e-05	0.00036	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—UMPS—stomach cancer	1.45e-05	0.000358	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—FBP1—stomach cancer	1.45e-05	0.000357	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CA1—stomach cancer	1.45e-05	0.000357	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NDUFA2—stomach cancer	1.45e-05	0.000357	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CKB—stomach cancer	1.45e-05	0.000357	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—HRAS—stomach cancer	1.43e-05	0.000354	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTT1—stomach cancer	1.42e-05	0.00035	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2A6—stomach cancer	1.4e-05	0.000346	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SREBF2—stomach cancer	1.37e-05	0.000338	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKR1C3—stomach cancer	1.36e-05	0.000337	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLIN2—stomach cancer	1.36e-05	0.000336	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—IDH3B—stomach cancer	1.35e-05	0.000335	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.35e-05	0.000335	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—RORA—stomach cancer	1.35e-05	0.000334	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ALB—stomach cancer	1.35e-05	0.000334	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PDHA1—stomach cancer	1.35e-05	0.000333	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ECHS1—stomach cancer	1.35e-05	0.000333	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ENO1—stomach cancer	1.33e-05	0.000328	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CA2—stomach cancer	1.32e-05	0.000327	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NT5E—stomach cancer	1.29e-05	0.000319	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PGAM1—stomach cancer	1.29e-05	0.000319	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALDOB—stomach cancer	1.27e-05	0.000313	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TYMP—stomach cancer	1.27e-05	0.000313	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—FADS1—stomach cancer	1.27e-05	0.000313	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.26e-05	0.000311	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.26e-05	0.000311	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—HRAS—stomach cancer	1.25e-05	0.000309	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.23e-05	0.000304	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLCE1—stomach cancer	1.23e-05	0.000304	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SREBF2—stomach cancer	1.19e-05	0.000293	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—UMPS—stomach cancer	1.18e-05	0.000291	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CD44—stomach cancer	1.18e-05	0.000291	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALOX5—stomach cancer	1.18e-05	0.000291	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—RORA—stomach cancer	1.17e-05	0.00029	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—DPYD—stomach cancer	1.16e-05	0.000286	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PGLS—stomach cancer	1.12e-05	0.000277	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BLVRB—stomach cancer	1.12e-05	0.000277	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDOB—stomach cancer	1.1e-05	0.000271	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PDHA1—stomach cancer	1.1e-05	0.000271	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ECHS1—stomach cancer	1.1e-05	0.000271	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.07e-05	0.000264	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.04e-05	0.000256	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.03e-05	0.000255	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—FADS1—stomach cancer	1.03e-05	0.000255	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TYMP—stomach cancer	1.03e-05	0.000255	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTT1—stomach cancer	1.03e-05	0.000253	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALOX5—stomach cancer	1.02e-05	0.000252	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2A6—stomach cancer	1.01e-05	0.00025	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—DPYD—stomach cancer	1e-05	0.000248	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPP2R1A—stomach cancer	1e-05	0.000248	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKR1C3—stomach cancer	9.86e-06	0.000244	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—stomach cancer	9.83e-06	0.000243	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMOX1—stomach cancer	9.69e-06	0.00024	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SREBF2—stomach cancer	9.65e-06	0.000238	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ENO1—stomach cancer	9.61e-06	0.000237	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NDUFA2—stomach cancer	9.54e-06	0.000236	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CKB—stomach cancer	9.54e-06	0.000236	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FBP1—stomach cancer	9.54e-06	0.000236	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CA1—stomach cancer	9.54e-06	0.000236	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—RORA—stomach cancer	9.53e-06	0.000236	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TYMS—stomach cancer	9.14e-06	0.000226	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.1e-06	0.000225	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—stomach cancer	9.03e-06	0.000223	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLIN2—stomach cancer	8.97e-06	0.000222	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDOB—stomach cancer	8.93e-06	0.000221	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—stomach cancer	8.88e-06	0.000219	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2A6—stomach cancer	8.78e-06	0.000217	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CA2—stomach cancer	8.72e-06	0.000216	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKR1C3—stomach cancer	8.54e-06	0.000211	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CD44—stomach cancer	8.52e-06	0.000211	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PGAM1—stomach cancer	8.5e-06	0.00021	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NT5E—stomach cancer	8.5e-06	0.00021	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ERCC2—stomach cancer	8.49e-06	0.00021	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.43e-06	0.000208	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.41e-06	0.000208	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ENO1—stomach cancer	8.32e-06	0.000206	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALOX5—stomach cancer	8.31e-06	0.000205	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.18e-06	0.000202	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—DPYD—stomach cancer	8.17e-06	0.000202	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLCE1—stomach cancer	8.11e-06	0.0002	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDH7A1—stomach cancer	8.11e-06	0.0002	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—stomach cancer	7.98e-06	0.000197	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—UMPS—stomach cancer	7.78e-06	0.000192	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.41e-06	0.000183	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CD44—stomach cancer	7.38e-06	0.000182	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAV1—stomach cancer	7.36e-06	0.000182	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOA1—stomach cancer	7.35e-06	0.000182	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPP2R1A—stomach cancer	7.24e-06	0.000179	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PDHA1—stomach cancer	7.23e-06	0.000179	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ECHS1—stomach cancer	7.23e-06	0.000179	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—stomach cancer	7.23e-06	0.000179	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.16e-06	0.000177	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2A6—stomach cancer	7.14e-06	0.000177	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—stomach cancer	7.11e-06	0.000176	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—stomach cancer	7.01e-06	0.000173	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKR1C3—stomach cancer	6.95e-06	0.000172	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TYMP—stomach cancer	6.8e-06	0.000168	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FADS1—stomach cancer	6.8e-06	0.000168	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ENO1—stomach cancer	6.77e-06	0.000167	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.66e-06	0.000165	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TYMS—stomach cancer	6.61e-06	0.000163	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—stomach cancer	6.53e-06	0.000161	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARG—stomach cancer	6.47e-06	0.00016	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SREBF2—stomach cancer	6.36e-06	0.000157	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—RORA—stomach cancer	6.29e-06	0.000155	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPP2R1A—stomach cancer	6.27e-06	0.000155	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—stomach cancer	6.15e-06	0.000152	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ERCC2—stomach cancer	6.14e-06	0.000152	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—stomach cancer	6.07e-06	0.00015	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CD44—stomach cancer	6.01e-06	0.000148	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDOB—stomach cancer	5.89e-06	0.000146	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.83e-06	0.000144	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—stomach cancer	5.82e-06	0.000144	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—stomach cancer	5.77e-06	0.000143	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TYMS—stomach cancer	5.72e-06	0.000141	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—stomach cancer	5.66e-06	0.00014	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NOS3—stomach cancer	5.57e-06	0.000138	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALOX5—stomach cancer	5.48e-06	0.000135	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DPYD—stomach cancer	5.39e-06	0.000133	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAV1—stomach cancer	5.32e-06	0.000132	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ERCC2—stomach cancer	5.32e-06	0.000131	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOA1—stomach cancer	5.31e-06	0.000131	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPP2R1A—stomach cancer	5.11e-06	0.000126	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—stomach cancer	5.09e-06	0.000126	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—stomach cancer	5.01e-06	0.000124	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—stomach cancer	5e-06	0.000124	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—stomach cancer	4.94e-06	0.000122	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—stomach cancer	4.77e-06	0.000118	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.71e-06	0.000116	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARG—stomach cancer	4.68e-06	0.000116	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TYMS—stomach cancer	4.66e-06	0.000115	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAV1—stomach cancer	4.61e-06	0.000114	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—stomach cancer	4.6e-06	0.000114	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOA1—stomach cancer	4.6e-06	0.000114	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.58e-06	0.000113	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ENO1—stomach cancer	4.47e-06	0.00011	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.4e-06	0.000109	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ERCC2—stomach cancer	4.33e-06	0.000107	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—stomach cancer	4.21e-06	0.000104	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—stomach cancer	4.07e-06	0.000101	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARG—stomach cancer	4.05e-06	0.0001	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NOS3—stomach cancer	4.02e-06	9.95e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CD44—stomach cancer	3.96e-06	9.79e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAV1—stomach cancer	3.75e-06	9.27e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA1—stomach cancer	3.74e-06	9.25e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—stomach cancer	3.68e-06	9.1e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—stomach cancer	3.64e-06	9.01e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.58e-06	8.86e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NOS3—stomach cancer	3.49e-06	8.61e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.37e-06	8.32e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—stomach cancer	3.3e-06	8.16e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARG—stomach cancer	3.3e-06	8.15e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—stomach cancer	3.26e-06	8.05e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—stomach cancer	3.19e-06	7.88e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—stomach cancer	3.13e-06	7.74e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TYMS—stomach cancer	3.07e-06	7.59e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—stomach cancer	3.04e-06	7.5e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—stomach cancer	2.97e-06	7.33e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ERCC2—stomach cancer	2.85e-06	7.05e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NOS3—stomach cancer	2.84e-06	7.01e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—stomach cancer	2.68e-06	6.63e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—stomach cancer	2.59e-06	6.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAV1—stomach cancer	2.47e-06	6.12e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA1—stomach cancer	2.47e-06	6.1e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—stomach cancer	2.26e-06	5.6e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARG—stomach cancer	2.18e-06	5.38e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.96e-06	4.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—stomach cancer	1.96e-06	4.83e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NOS3—stomach cancer	1.87e-06	4.62e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—stomach cancer	1.71e-06	4.23e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.6e-06	3.95e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.05e-06	2.6e-05	CbGpPWpGaD
